Sorbello A - Search Results

1

Progressive multifocal leukoencephalopathy after natalizumab discontinuation.

Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Fine AJ, et al. Among authors: sorbello a. Ann Neurol. 2014 Jan;75(1):108-15. doi: 10.1002/ana.24051. Ann Neurol. 2014. PMID: 24242357

2

Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.

Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Fine AJ, et al. Among authors: sorbello a. Clin Infect Dis. 2013 Sep;57(6):849-52. doi: 10.1093/cid/cit376. Epub 2013 May 31. Clin Infect Dis. 2013. PMID: 23728144

3

Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.

Winnenburg R, Sorbello A, Ripple A, Harpaz R, Tonning J, Szarfman A, Francis H, Bodenreider O. Winnenburg R, et al. Among authors: sorbello a. J Biomed Inform. 2015 Oct;57:425-35. doi: 10.1016/j.jbi.2015.08.022. Epub 2015 Sep 2. J Biomed Inform. 2015. PMID: 26342964 Free PMC article.

4

A time-indexed reference standard of adverse drug reactions.

Harpaz R, Odgers D, Gaskin G, DuMouchel W, Winnenburg R, Bodenreider O, Ripple A, Szarfman A, Sorbello A, Horvitz E, White RW, Shah NH. Harpaz R, et al. Among authors: sorbello a. Sci Data. 2014 Nov 11;1:140043. doi: 10.1038/sdata.2014.43. Sci Data. 2014. PMID: 25632348 Free PMC article.

5

Neonatal Safety Information Reported to the FDA During Drug Development Studies.

Avant D, Baer G, Moore J, Zheng P, Sorbello A, Ariagno R, Yao L, Burckart GJ, Wang J. Avant D, et al. Among authors: sorbello a. Ther Innov Regul Sci. 2017;2017:1-9. doi: 10.1177/2168479017716713. Epub 2017 Jun 28. Ther Innov Regul Sci. 2017. PMID: 28804696 Free PMC article.

6

Toward multimodal signal detection of adverse drug reactions.

Harpaz R, DuMouchel W, Schuemie M, Bodenreider O, Friedman C, Horvitz E, Ripple A, Sorbello A, White RW, Winnenburg R, Shah NH. Harpaz R, et al. Among authors: sorbello a. J Biomed Inform. 2017 Dec;76:41-49. doi: 10.1016/j.jbi.2017.10.013. Epub 2017 Nov 1. J Biomed Inform. 2017. PMID: 29081385 Free article.

7

Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing.

Sorbello A, Ripple A, Tonning J, Munoz M, Hasan R, Ly T, Francis H, Bodenreider O. Sorbello A, et al. Appl Clin Inform. 2017 Mar 22;8(1):291-305. doi: 10.4338/ACI-2016-11-RA-0188. Appl Clin Inform. 2017. PMID: 28326432 Free PMC article.

8

Reply: To PMID 24242357.

Fine AJ, Sorbello A, Kortepeter C. Fine AJ, et al. Among authors: sorbello a. Ann Neurol. 2014 Mar;75(3):462-3. doi: 10.1002/ana.24108. Epub 2014 Mar 7. Ann Neurol. 2014. PMID: 24443375 No abstract available.

9

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Sorbello A, Jones SC, Carter W, Struble K, Boucher R, Truffa M, Birnkrant D, Gada N, Camilli S, Chan I, Dallas S, Scales T, Kosko R, Thompson E, Goodman J, Francis H, Dal Pan G. Sorbello A, et al. Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5. Clin Infect Dis. 2012. PMID: 22491501

10

Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Jones SC, Sorbello A, Boucher RM. Jones SC, et al. Among authors: sorbello a. Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000. Drug Saf. 2011. PMID: 21879778 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results